Literature DB >> 31542786

Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma.

Ilgin Yildirim Simsir1, Sevki Cetinkalp2, Taylan Kabalak2.   

Abstract

There is an increased incidence of thyroid nodules and cancer. In this article, the reasons for this increase are evaluated and discussed. The factors causing increases in the incidence of nodules are the same as those causing increases in thyroid cancer. There are publications from all over the world regarding the rising incidence of thyroid cancer; it is especially associated with papillary cancer. The literature was reviewed and evaluated with regard to this significant phenomenon. Thyroid-stimulating hormone (TSH) is the main mitotic factor. Any agent that elevates TSH will stimulate nodule formation. Therefore, the incidence of thyroid nodules is high in endemic goiter regions due to iodine deficiency. This paper has described many of the factors causing this higher incidence. Of note, metabolic syndrome and insulin resistance are important factors associated with the increased incidence of nodular goiter and papillary thyroid cancer today. However, these data must be confirmed by other studies in the future.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Nodular goiter; Thyroid cancer

Mesh:

Substances:

Year:  2019        PMID: 31542786      PMCID: PMC7024874          DOI: 10.1159/000503575

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  33 in total

Review 1.  Thyroid nodules.

Authors:  Geanina Popoveniuc; Jacqueline Jonklaas
Journal:  Med Clin North Am       Date:  2012-03       Impact factor: 5.456

2.  The Prevalence of Thyroid Nodules and Their Association with Metabolic Syndrome Risk Factors in a Moderate Iodine Intake Area.

Authors:  Shangyong Feng; Zhenwen Zhang; Shuhang Xu; Xiaodong Mao; Yu Feng; Yan Zhu; Chao Liu
Journal:  Metab Syndr Relat Disord       Date:  2016-12-08       Impact factor: 1.894

3.  Association of obesity and diabetes with thyroid nodules.

Authors:  Silvio Buscemi; Fatima Maria Massenti; Sonya Vasto; Fabio Galvano; Carola Buscemi; Davide Corleo; Anna Maria Barile; Giuseppe Rosafio; Nadia Rini; Carla Giordano
Journal:  Endocrine       Date:  2017-08-23       Impact factor: 3.633

Review 4.  The IGF system in thyroid cancer: new concepts.

Authors:  V Vella; L Sciacca; G Pandini; R Mineo; S Squatrito; R Vigneri; A Belfiore
Journal:  Mol Pathol       Date:  2001-06

Review 5.  Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules.

Authors:  William Clinkscales; Adrian Ong; Shaun Nguyen; Elizabeth Emily Harruff; Marion Boyd Gillespie
Journal:  Otolaryngol Head Neck Surg       Date:  2017-01-24       Impact factor: 3.497

6.  Thyroid disorders in obese patients. Does insulin resistance make a difference?

Authors:  Nicoleta Răcătăianu; Nicoleta Leach; Cosmina Ioana Bondor; Smaranda Mârza; Daniela Moga; Ana Valea; Cristina Ghervan
Journal:  Arch Endocrinol Metab       Date:  2017-12       Impact factor: 2.309

Review 7.  Role of leptin and its receptors in the pathogenesis of thyroid cancer.

Authors:  Shahab Uddin; Azhar R Hussain; Abdul K Siraj; Omar S Khan; Prashant P Bavi; Khawla S Al-Kuraya
Journal:  Int J Clin Exp Pathol       Date:  2011-10-03

8.  Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.

Authors:  Michael B Zimmermann; Valeria Galetti
Journal:  Thyroid Res       Date:  2015-06-18

9.  Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines.

Authors:  Safar Kheder; Karen Sisley; Sirwan Hadad; Sabapathy P Balasubramanian
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

Review 10.  The Role of Insulin Resistance/Hyperinsulinism on the Rising Trend of Thyroid and Adrenal Nodular Disease in the Current Environment.

Authors:  Agathocles Tsatsoulis
Journal:  J Clin Med       Date:  2018-02-26       Impact factor: 4.241

View more
  7 in total

Review 1.  Mechanism Study on Chinese Medicine in Treatment of Nodular Goiter.

Authors:  Chang-Lin Wang; Ming-Zhou Gao; Xiang-Ju Gao; Xiang-Yu Mu; Jie-Qiong Wang; Dong-Mei Gao; Ming-Qi Qiao
Journal:  Chin J Integr Med       Date:  2022-08-31       Impact factor: 2.626

2.  Adherence to the Mediterranean Diet as a Modifiable Risk Factor for Thyroid Nodular Disease and Thyroid Cancer: Results From a Pilot Study.

Authors:  Luigi Barrea; Giovanna Muscogiuri; Giulia de Alteriis; Tommaso Porcelli; Claudia Vetrani; Ludovica Verde; Sara Aprano; Francesco Fonderico; Giancarlo Troncone; Annamaria Colao; Silvia Savastano
Journal:  Front Nutr       Date:  2022-06-17

3.  Katanin subunits p60 and p80, potential biomarkers for papillary thyroid carcinoma to distinguish nodular goiter: STROBE.

Authors:  Zhangming Wu; Miao Guo; Jing Yang; Yanjie Xiao; Wei Liu
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

4.  An analysis of the correlation between thyroid nodules and metabolic syndrome.

Authors:  Ling Hu; Ting Li; Xiao-Ling Yin; Yi Zou
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335

5.  Differential gene expression profile of multinodular goiter.

Authors:  Wenberger Lanza Daniel de Figueiredo; Eraldo Ferreira Lopes; Deborah Laredo Jezini; Lorena Naciff Marçal; Enedina Nogueira de Assunção; Paulo Rodrigo Ribeiro Rodrigues; Adolfo José da Mota; Diego Monteiro de Carvalho; Spartaco Astolfi Filho; João Bosco Lopes Botelho
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

6.  Benign nodules of the thyroid gland and 25-hydroxy-vitamin D levels in euthyroid patients.

Authors:  Hacı Bolat; Aliriza Erdoğan
Journal:  Ann Saudi Med       Date:  2022-04-07       Impact factor: 1.526

7.  Clinical Significance of Erythrocyte Sedimentation Rate, Leukocyte, Fibrinogen, C-Reactive Protein, and Pentraxin 3 Values in Thyroid Nodules.

Authors:  Sabahattin Destek; Beyza Benturk; Yunus Yapalak; Omer Faruk Ozer
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.